Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis

PURPOSE: Intravenous (IV) zoledronic acid (ZA) is commonly used to delay skeletal complications secondary to bone metastases. However, the time associated with ZA administration may represent a significant burden to healthcare providers and patients. This study assessed the time associated with IV Z...

Descripción completa

Detalles Bibliográficos
Autores principales: Richhariya, Akshara, Qian, Yi, Zhao, Yufan, Chung, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304336/
https://www.ncbi.nlm.nih.gov/pubmed/22427731
http://dx.doi.org/10.2147/CMAR.S27693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304336/
https://www.ncbi.nlm.nih.gov/pubmed/22427731
http://dx.doi.org/10.2147/CMAR.S27693

Ejemplares similares